807. Trimethoprim/Sulfamethoxazole for Pneumocystis jirovecii pneumonia prophylaxis in B-cell lymphoma: A multicenter randomized double-blinded placebo-controlled trial

BACKGROUND: The studies to compare the efficacy and safety of trimethoprim/sulfamethoxazole (TMP/SMX) for Pneumocystis jirovecii pneumonia (PJP) prophylaxis in lymphoma patients are scared. METHODS: A multicenter randomized double-blinded placebo-controlled trial was conducted in adult B-cell lympho...

Descripción completa

Detalles Bibliográficos
Autores principales: Angsutararux, Taksaon, Wongwatcharanon, Kiattikon, Dhitinanmuang, Wutthiseth, Chintabanyat, Anothai, Jit-Ueakul, Dusit, Owattanapanich, Weerapat, Karoopongse, Ekapun, Jangkananun, Piyanut, Piyabun-yanon, Chavada, Munsakul, Warangkana, Chayakulkeeree, Methee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678785/
http://dx.doi.org/10.1093/ofid/ofad500.852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678785/
http://dx.doi.org/10.1093/ofid/ofad500.852

Ejemplares similares